Loading clinical trials...
Loading clinical trials...
Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in Patients With HIV. Influence on Morphological and Metabolic Disorders. A Randomized, Open-Label Multicenter Trial.
Conditions
Interventions
nucleoside analogue sparing HAART regimen
Locations
5
Denmark
Department of Infectious Diseases, Hvidovre University Hospital
Hvidovre, Copenhagen, Denmark
Department of Infectious Diseases, Aalborg Hospital
Aalborg, Denmark
Department of Infectious Diseases, Aarhus University Hospital
Aarhus, Denmark
Department of Infectious Diseases, Rigshospitalet
Copenhagen, Denmark
Department of Infectious Diseases, Odense University Hospital
Odense, Denmark
Start Date
June 1, 2003
Completion Date
November 1, 2007
Last Updated
March 14, 2006
NCT04340388
NCT00069004
NCT01359917
NCT00122226
Lead Sponsor
Danish HIV Research Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions